schliessen

Filtern

 

Bibliotheken

SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?

In the recent past people have been fortunate to find new treatments based on entirely new mechanisms. The sodium-glucose cotransporter inhibitors (SGLTi) offer an instructive case in point. These apparently "new" agents were preceded by phlorizin, a naturally occurring compound that has been used f... Full description

Journal Title: Diabetes care December 2018, Vol.41(12), pp.2444-2447
Main Author: Riddle, Matthew C
Other Authors: Cefalu, William T
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1935-5548 ; PMID: 30459245 Version:1 ; DOI: 10.2337/dci18-0041
Link: http://pubmed.gov/30459245
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline30459245
title: SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?
format: Article
creator:
  • Riddle, Matthew C
  • Cefalu, William T
subjects:
  • United States–Us
  • Diabetes
  • Research & Development–R&D
  • Insulin
  • Prescription Drugs
  • Intestine
  • Intestinal Absorption
  • Carbohydrates
  • Insulin
  • Diabetes
  • Sodium
  • Insulin
  • Diabetes Mellitus (Insulin Dependent)
  • Diabetes Mellitus
  • Hyperglycemia
  • Inhibitors
ispartof: Diabetes care, December 2018, Vol.41(12), pp.2444-2447
description: In the recent past people have been fortunate to find new treatments based on entirely new mechanisms. The sodium-glucose cotransporter inhibitors (SGLTi) offer an instructive case in point. These apparently "new" agents were preceded by phlorizin, a naturally occurring compound that has been used for...
language: eng
source:
identifier: E-ISSN: 1935-5548 ; PMID: 30459245 Version:1 ; DOI: 10.2337/dci18-0041
fulltext: fulltext
issn:
  • 19355548
  • 1935-5548
url: Link


@attributes
ID1636834222
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid30459245
sourceidmedline
recordidTN_medline30459245
sourceformatXML
sourcesystemPC
pqid2136557390
display
typearticle
titleSGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?
creatorRiddle, Matthew C ; Cefalu, William T
ispartofDiabetes care, December 2018, Vol.41(12), pp.2444-2447
identifier
languageeng
source
subjectUnited States–Us ; Diabetes ; Research & Development–R&D ; Insulin ; Prescription Drugs ; Intestine ; Intestinal Absorption ; Carbohydrates ; Insulin ; Diabetes ; Sodium ; Insulin ; Diabetes Mellitus (Insulin Dependent) ; Diabetes Mellitus ; Hyperglycemia ; Inhibitors;
descriptionIn the recent past people have been fortunate to find new treatments based on entirely new mechanisms. The sodium-glucose cotransporter inhibitors (SGLTi) offer an instructive case in point. These apparently "new" agents were preceded by phlorizin, a naturally occurring compound that has been used for...
version4
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/30459245$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontrib
0Riddle, Matthew C
1Cefalu, William T
titleSGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?
general
030459245
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
310.2337/dci18-0041
4MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline30459245
issn
019355548
11935-5548
rsrctypearticle
creationdate2018
addtitleDiabetes care
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
lsr412018
citationpf 2444 vol 41 issue 12
startdate20181201
enddate20181231
lsr30VSR-Enriched:[subject, date, description, pqid]
sort
titleSGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?
authorRiddle, Matthew C ; Cefalu, William T
creationdate20181200
lso0120181200
facets
frbrgroupid8494128774369023682
frbrtype5
newrecords20190701
languageeng
creationdate2018
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontrib
0Riddle, Matthew C
1Cefalu, William T
jtitleDiabetes Care
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Riddle
1Cefalu
aufirst
0Matthew C
1William T
au
0Riddle, Matthew C
1Cefalu, William T
atitleSGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?
jtitleDiabetes care
risdate201812
volume41
issue12
spage2444
pages2444-2447
issn0149-5992
eissn1935-5548
formatjournal
genrearticle
ristypeJOUR
doi10.2337/dci18-0041
pmid30459245
date2018-12-01